e-learning
resources
Copenhagen 2005
Monday 19.09.2005
The many faces of sarcoidosis II
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The importance value of persistance hypercalciuria in sarcoidosis patients
J. L. Videnovic-Ivanov, V. M. Vucinic, V. R. Zugic (Belgrade, Serbia And Montenegro)
Source:
Annual Congress 2005 - The many faces of sarcoidosis II
Session:
The many faces of sarcoidosis II
Session type:
Thematic Poster Session
Number:
2178
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. L. Videnovic-Ivanov, V. M. Vucinic, V. R. Zugic (Belgrade, Serbia And Montenegro). The importance value of persistance hypercalciuria in sarcoidosis patients. Eur Respir J 2005; 26: Suppl. 49, 2178
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Pulmonary sarcoidosis
Definition and history of sarcoidosis
ERS clinical practice guidelines on treatment of sarcoidosis
Related content which might interest you:
The prevalence and clinical implications of bronchiectasis in patients with sarcoidosis
Source: International Congress 2019 – Sarcoidosis: a multifaceted disease that is difficult to manage
Year: 2019
The importance of defined comorbities in sarcoidosis
Source: Annual Congress 2010 - Clinical issues in diffuse parenchymal lung disease
Year: 2010
The value of urinary calcium as biomarker in chronic sarcoidosis
Source: Virtual Congress 2020 – Genetics and biomarkers for diagnosis and prognosis of granulomatous lung diseases
Year: 2020
The radiographic bronchiectasis in patients with COPD-OSA overlap syndrome
Source: International Congress 2019 – Bronchiectasis
Year: 2019
The role of obesity in patients with sarcoidosis
Source: International Congress 2019 – Granulomatous disorders: pathogenesis, epidemiology and clinical issues
Year: 2019
The features of patients with sarcoidosis
Source: Eur Respir J 2002; 20: Suppl. 38, 436s
Year: 2002
The clinical relevance of autoimmunity in idiopathic pulmonary fibrosis
Source: Annual Congress 2012 - Diffuse parenchymal lung disease II
Year: 2012
Renal failure as first manifestation of familial sarcoidosis
Source: Eur Respir J 2010; 36: 1485-1487
Year: 2010
The comparison of sarcoidosis patients with benign and recurrent clinical course of the disease
Source: Eur Respir J 2005; 26: Suppl. 49, 331s
Year: 2005
Significance of abnormal autoantibodies in patients presenting with IPF
Source: Annual Congress 2012 - Idiopathic pulmonary fibrosis
Year: 2012
Clinical implications of ANCA positivity in idiopathic pulmonary fibrosis patients
Source: Breathe, 16 (1) 190321; 10.1183/20734735.0321-2019
Year: 2020
The role of bronchoscopy in the differential diagnosis of pulmonary lesions in end-stage renal disease patients
Source: Virtual Congress 2020 – Conventional bronchoscopy
Year: 2020
Hyaluroman syntehase-2 over expression has impact in the evolution and on the prognosis of idiopathic pulmonary fibrosis patients
Source: Annual Congress 2012 - Idiopathic pulmonary fibrosis
Year: 2012
Peculiarities of the articular syndrome in sarcoidosis patients with hystologically verified intrathoracic sarcoidosis
Source: Annual Congress 2009 - Pleural and parenchymal diseases
Year: 2009
Prognostic significance of serum markers in acute exacerbation of idiopathic interstitial pneumonias
Source: Annual Congress 2011 - Clinical perspectives in several interstitial diseases
Year: 2011
Importance of fatigue measurement in sarcoidosis patients
Source: Annual Congress 2011 - New insights in management of interstitial and vascular lung diseases
Year: 2011
Prevalence of ocular sarcoidosis in patients with intra thoracic sarcoidosis
Source: International Congress 2016 – The best clinical approach to lung diseases
Year: 2016
Clinical significance of serum CA 15-3 in patients with idiopathic interstitial pneumonias
Source: Annual Congress 2007 - Interstitial lung disease: diagnostic and therapeutic novelties
Year: 2007
Diagnostic and prognostic value of an undifferentiated connective tissue disease index in idiopathic interstitial pneumonia
Source: Annual Congress 2009 - From genetics to clinics in diffuse parenchymal lung diseases
Year: 2009
Prognostic significance of clinical and morphological features in idiopathic interstitial pneumonias
Source: Eur Respir J 2002; 20: Suppl. 38, 61s
Year: 2002
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept